Get informed when a big investor buys or sells
+ FollowOvervalued by 177.6% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $2.95 Million |
|---|---|
| Enterprise Value | $3.86 Million |
| Earnings per Share | $-0.39 |
| Beta | -1.18 |
| Outstanding Shares | 28,055,593 |
| P/E Ratio | -0.36 |
|---|---|
| PEG | 0.3 |
| Price to Sales | - |
| Price to Book Ratio | -0.11 |
| Enterprise Value to Revenue | 1.22 |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | -1.04 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide ...